|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.870 USD | +1.77% |
|
-1.71% | +4.36% |
| Market Cap | 322M 282M 264M 242M 454M 30.82B 461M 3.11B 1.22B 15.24B 1.21B 1.18B 52.7B | P/E 2026 * |
-2.56x | P/E 2027 * | -2.49x |
|---|---|---|---|---|---|
| Enterprise Value | 134M 118M 110M 101M 190M 12.89B 193M 1.3B 510M 6.37B 505M 494M 22.04B | EV / Sales 2026 * |
318x | EV / Sales 2027 * | 19.1x |
| Free-Float |
89.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | +1.77% | ||
| 1 week | -1.71% | ||
| Current month | -15.84% | ||
| 1 month | -5.59% | ||
| 3 months | -32.79% | ||
| 6 months | +6.30% | ||
| Current year | +4.36% |
| 1 week | 2.69 |  | 3.03 |
| 1 month | 2.69 | | 3.78 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 2023-02-04 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 2025-09-03 |
Paul Lyne
CTO | Chief Tech/Sci/R&D Officer | - | 2026-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 2023-02-04 |
Lori Woods
CHM | Chairman | 63 | 2023-02-02 |
| Director/Board Member | 60 | 2023-02-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/2/26 | Free | Chief Technology Officer | 150,000 | 0.1317% | ||
| 3/2/26 | Free | Director | 50,000 | 0.0439% | ||
| 3/2/26 | Free | Chairman | 50,000 | 0.0439% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | -1.71% | -29.31% | -50.94% | 322M | |
| +0.14% | -0.85% | -1.20% | +11.73% | 47.74B | |
| -2.24% | +1.92% | +385.05% | +630.47% | 39.98B | |
| +1.40% | +6.40% | +13.38% | +57.74% | 36.23B | |
| +13.94% | +19.15% | +21.98% | +8.18% | 35.59B | |
| -0.73% | +2.78% | +4.65% | +41.16% | 27.91B | |
| +0.40% | +1.06% | - | - | 16.71B | |
| -3.12% | +8.15% | +27.59% | +129.42% | 16.45B | |
| +2.39% | -3.63% | -0.35% | +10.34% | 13.21B | |
| +6.79% | +8.46% | -3.62% | -25.41% | 12.93B | |
| Average | +0.69% | +2.16% | +46.46% | +90.30% | 24.71B | |
| Weighted average by Cap. | +0.11% | +2.95% | +74.35% | +135.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423K 372K 347K 319K 597K 40.56M 607K 4.1M 1.61M 20.05M 1.59M 1.55M 69.34M | 488K 428K 400K 367K 688K 46.73M 699K 4.72M 1.85M 23.1M 1.83M 1.79M 79.89M |
| Net income | -120M -106M -98.44M -90.43M -169M -11.51B -172M -1.16B -456M -5.69B -451M -441M -19.68B | -138M -121M -113M -104M -195M -13.24B -198M -1.34B -524M -6.54B -519M -507M -22.64B |
| Net Debt | -187M -164M -153M -141M -264M -17.93B -268M -1.81B -710M -8.86B -702M -687M -30.66B | -312M -274M -256M -235M -440M -29.93B -448M -3.02B -1.18B -14.79B -1.17B -1.15B -51.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | US$2.870 | +1.77% | 998,928 |
| 26-07-27 | US$2.820 | -3.09% | 812,765 |
| 26-07-24 | US$2.910 | -1.36% | 671,334 |
| 26-07-23 | US$2.950 | -0.67% | 582,707 |
| 26-07-22 | US$2.970 | -0.34% | 1,151,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
